rs41289902

Variant summary

Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_001105206.3(LAMA4):​c.3239G>A​(p.Arg1080Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0121 in 1,614,076 control chromosomes in the GnomAD database, including 157 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.010 ( 5 hom., cov: 33)
Exomes 𝑓: 0.012 ( 152 hom. )

Consequence

LAMA4
NM_001105206.3 missense

Scores

6
5
6

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:15

Conservation

PhyloP100: 7.38
Variant links:
Genes affected
LAMA4 (HGNC:6484): (laminin subunit alpha 4) Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Laminins are composed of 3 non identical chains: laminin alpha, beta and gamma (formerly A, B1, and B2, respectively) and they form a cruciform structure consisting of 3 short arms, each formed by a different chain, and a long arm composed of all 3 chains. Each laminin chain is a multidomain protein encoded by a distinct gene. Several isoforms of each chain have been described. Different alpha, beta and gamma chain isomers combine to give rise to different heterotrimeric laminin isoforms which are designated by Arabic numerals in the order of their discovery, i.e. alpha1beta1gamma1 heterotrimer is laminin 1. The biological functions of the different chains and trimer molecules are largely unknown, but some of the chains have been shown to differ with respect to their tissue distribution, presumably reflecting diverse functions in vivo. This gene encodes the alpha chain isoform laminin, alpha 4. The domain structure of alpha 4 is similar to that of alpha 3, both of which resemble truncated versions of alpha 1 and alpha 2, in that approximately 1,200 residues at the N-terminus (domains IV, V and VI) have been lost. Laminin, alpha 4 contains the C-terminal G domain which distinguishes all alpha chains from the beta and gamma chains. The RNA analysis from adult and fetal tissues revealed developmental regulation of expression, however, the exact function of laminin, alpha 4 is not known. Tissue-specific utilization of alternative polyA-signal has been described in literature. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Aug 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.017812014).
BP6
Variant 6-112139163-C-T is Benign according to our data. Variant chr6-112139163-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 44374.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-112139163-C-T is described in Lovd as [Benign]. Variant chr6-112139163-C-T is described in Lovd as [Likely_benign].
BS2
High AC in GnomAd4 at 1521 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
LAMA4NM_001105206.3 linkuse as main transcriptc.3239G>A p.Arg1080Gln missense_variant 24/39 ENST00000230538.12 NP_001098676.2
LOC107986633XR_001744299.2 linkuse as main transcriptn.440-16157C>T intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
LAMA4ENST00000230538.12 linkuse as main transcriptc.3239G>A p.Arg1080Gln missense_variant 24/391 NM_001105206.3 ENSP00000230538 A1

Frequencies

GnomAD3 genomes
AF:
0.0100
AC:
1522
AN:
152156
Hom.:
5
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00212
Gnomad AMI
AF:
0.00768
Gnomad AMR
AF:
0.0104
Gnomad ASJ
AF:
0.00778
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.0244
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0141
Gnomad OTH
AF:
0.00766
GnomAD3 exomes
AF:
0.0103
AC:
2597
AN:
251242
Hom.:
21
AF XY:
0.0103
AC XY:
1396
AN XY:
135774
show subpopulations
Gnomad AFR exome
AF:
0.00197
Gnomad AMR exome
AF:
0.00763
Gnomad ASJ exome
AF:
0.00675
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.00219
Gnomad FIN exome
AF:
0.0242
Gnomad NFE exome
AF:
0.0139
Gnomad OTH exome
AF:
0.0103
GnomAD4 exome
AF:
0.0123
AC:
17934
AN:
1461802
Hom.:
152
Cov.:
31
AF XY:
0.0120
AC XY:
8730
AN XY:
727210
show subpopulations
Gnomad4 AFR exome
AF:
0.00158
Gnomad4 AMR exome
AF:
0.00762
Gnomad4 ASJ exome
AF:
0.00681
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00204
Gnomad4 FIN exome
AF:
0.0231
Gnomad4 NFE exome
AF:
0.0138
Gnomad4 OTH exome
AF:
0.0105
GnomAD4 genome
AF:
0.00999
AC:
1521
AN:
152274
Hom.:
5
Cov.:
33
AF XY:
0.0103
AC XY:
770
AN XY:
74450
show subpopulations
Gnomad4 AFR
AF:
0.00209
Gnomad4 AMR
AF:
0.0104
Gnomad4 ASJ
AF:
0.00778
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00124
Gnomad4 FIN
AF:
0.0244
Gnomad4 NFE
AF:
0.0141
Gnomad4 OTH
AF:
0.00758
Alfa
AF:
0.0125
Hom.:
32
Bravo
AF:
0.00884
TwinsUK
AF:
0.0162
AC:
60
ALSPAC
AF:
0.0138
AC:
53
ESP6500AA
AF:
0.00227
AC:
10
ESP6500EA
AF:
0.0130
AC:
112
ExAC
AF:
0.00999
AC:
1213
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:15
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:8
Benign, criteria provided, single submitterresearchBiesecker Lab/Clinical Genomics Section, National Institutes of HealthJun 24, 2013- -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineJan 31, 2012Arg1073Gln in exon 24 of LAMA4: This variant is classified as benign based on i ts high frequency in the general population (rs41289902; http://evs.gs.washingto n.edu/EVS/). -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingGeneDxFeb 06, 2014This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Likely benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpJul 21, 2023- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jun 11, 2013- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Dilated cardiomyopathy 1JJ Benign:5
Likely benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, criteria provided, single submitterclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical CenterSep 21, 2015- -
Benign, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, University Medical Center UtrechtOct 09, 2014- -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesOct 26, 2023- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Cardiomyopathy Benign:1
Benign, criteria provided, single submitterclinical testingCHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern OntarioJun 27, 2016- -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2023LAMA4: BS1, BS2 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
0.0086
T
BayesDel_noAF
Pathogenic
0.25
CADD
Pathogenic
32
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.031
T;T;T;T
Eigen
Pathogenic
0.77
Eigen_PC
Pathogenic
0.80
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.91
D;.;.;D
MetaRNN
Benign
0.018
T;T;T;T
MetaSVM
Uncertain
0.13
D
MutationTaster
Benign
1.0
D;D;D;D
PrimateAI
Uncertain
0.56
T
PROVEAN
Benign
-0.85
N;N;N;N
REVEL
Pathogenic
0.67
Sift
Pathogenic
0.0
D;D;D;D
Sift4G
Uncertain
0.059
T;T;T;T
Vest4
0.97
MPC
0.61
ClinPred
0.047
T
GERP RS
6.0
gMVP
0.74

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs41289902; hg19: chr6-112460365; API